HealthTree Logo
search more_vert
close
person Sign In / Create Account
What Is The Risk Of Relapse With MDS?
Posted: Apr 11, 2024
What Is The Risk Of Relapse With MDS? image

Myelodysplastic syndromes are a group of blood disorders that affect how bone marrow makes blood cells. They can lead to low blood cell counts (cytopenia) and the inability of bone marrow cells to develop properly (dysplasia). 

MDS is considered incurable if treated only with chemotherapy, and not all patients who undergo a bone marrow transplant are cured. Research studies focus on expanding alternatives for patients who can’t receive a transplant to get closer to a cure. When a patient has a good response, that means after receiving treatment and having no MDS, it stays that way for some time, but eventually, it returns. 

MDS patients are classified according to the risk of their disease progressing into acute leukemia. The therapies administered and treatment goals will be adapted to that risk: 

  • For low-risk patients, doctors will try to minimize any symptoms with medication as much as possible.
  • For high-risk patients, treatment options will be more aggressive, like a bone marrow transplant, to try to control the underlying disease for as long as possible.

HealthTree University for MDS offers a comprehensive online curriculum with lessons, quizzes, and course discussions. Create a free account today to track your progress and stay up to date on the latest advancements in treating MDS!

CREATE A FREE ACCOUNT

We've partnered with MDS experts to help you learn quickly, improve how you navigate your disease, and obtain better outcomes with HealthTree University. Stay up to date on the latest MDS news through our newsletter: 

HEALTHTREE NEWSLETTER

The author Jimena Vicencio

about the author
Jimena Vicencio

Jimena is an International Medical Graduate who is part of the HealthTree Patient Experience team. She loves learning new things led by her curiosity, playing with her pets, and exercising in her free time.

Get the latest thought leadership on Leukemia delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Leukemia Newsletter" for Leukemia news, life with Leukemia stories, Leukemia clinical trials, Leukemia 101 articles and events with Leukemia experts.